Procurement Summary
Country: USA
Summary: Single Domain Antibody Development Service
Deadline: 24 May 2026
Posting Date: 15 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141325558
Document Ref. No.: 75N98026Q00360
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
COMBINED SYNOPSIS / SOLICITATION WORKFORM
Action Code: Combined Synopsis/Solicitation
Date: May 14
Year: 2026
Contracting Office Zip Code: 20817
Classification Code: 2651
Contracting Office Address:
6701 Rockledge Drive
Bethesda, MD 20817
Subject/Title: Single Domain Antibody Development Service
Solicitation Number: 26-003384
Closing Response Date: May 24, 2026 @ 9am. Eastern Daylight Time (EDT)
Contact Point(s): Towanda Daniels, Purchasing Agent
Contract Award Type: Firm Fixed Price
Brand Name or Equal Acquisition (FAR 52.211-6): No
Description:
“This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a written solicitation will not be issued.”
The solicitation number and a statement that the solicitation is issued as a request for quote (RFQ).
The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, FAC Number: 2026-01
Effective Date: 03/13/2026
This solicitation is being released unrestricted. The NAICS code is 541714, and the small business size standard is 1000 employees. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has a requirement to generate a custom Single-Domain Antibody to the extracellular domain of the human Calcium-Sensing Receptor (CASR). This custom Single-Domain Antibody will enable the generation of a Variable Heavy-based injectable bioreagent specifically targeting the human Calcium-Sensing Receptor for use in parathyroid tumor Positron Emission Tomography -scanning, imaging, and localization and/or as a radiopharmaceutical treatment for inop...
Notice ID: 75n98026q00360
Department/Ind. Agency: health and human services, department of
Original Set Aside: total small business set-aside (far 19.5)
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6550 - in vitro diagnostic substances, reagents, test kits and sets
NAICS Code: 541380 - Testing Laboratories and Services
Inactive Dates: jun 08, 2026
Inactive Policy: 15 days after date offers due
Documents
Tender Notice
Documents.zip